NasdaqGS - Delayed Quote USD

Amedisys, Inc. (AMED)

94.43 -0.52 (-0.55%)
At close: May 17 at 4:00 PM EDT
94.43 0.00 (0.00%)
After hours: May 17 at 4:20 PM EDT
Loading Chart for AMED
DELL
  • Previous Close 94.95
  • Open 95.01
  • Bid 94.38 x 100
  • Ask 94.51 x 100
  • Day's Range 94.29 - 95.35
  • 52 Week Range 74.61 - 96.44
  • Volume 196,779
  • Avg. Volume 281,276
  • Market Cap (intraday) 3.086B
  • Beta (5Y Monthly) 0.84
  • PE Ratio (TTM) --
  • EPS (TTM) -0.64
  • Earnings Date Jul 24, 2024 - Jul 29, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 97.78

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

www.amedisys.com

18,700

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AMED

Performance Overview: AMED

Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

AMED
0.66%
S&P 500
11.18%

1-Year Return

AMED
24.28%
S&P 500
29.04%

3-Year Return

AMED
63.25%
S&P 500
27.06%

5-Year Return

AMED
15.86%
S&P 500
84.38%

Compare To: AMED

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AMED

Valuation Measures

Annual
As of 5/17/2024
  • Market Cap

    3.09B

  • Enterprise Value

    3.46B

  • Trailing P/E

    --

  • Forward P/E

    20.83

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.37

  • Price/Book (mrq)

    2.84

  • Enterprise Value/Revenue

    1.54

  • Enterprise Value/EBITDA

    28.30

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.92%

  • Return on Assets (ttm)

    6.26%

  • Return on Equity (ttm)

    -1.87%

  • Revenue (ttm)

    2.25B

  • Net Income Avi to Common (ttm)

    -20.59M

  • Diluted EPS (ttm)

    -0.64

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    108.23M

  • Total Debt/Equity (mrq)

    42.17%

  • Levered Free Cash Flow (ttm)

    243.26M

Research Analysis: AMED

Company Insights: AMED

Research Reports: AMED

People Also Watch